“We’re all reading the tea leaves.” — Paul Offit, MD, of Children’s Hospital of Philadelphia, discussing Pfizer’s application for authorization of its COVID-19 vaccine in kids under 5, amid numerous questions over the data.
“It’s enough to gag a maggot.” — Senator Elizabeth Warren (D-Mass.), during a hearing on Medicare financing, railing against tactics employed by pharmaceutical companies that keep drug prices high.
“It’s not an evidence-based discussion of the pros and cons.” — Mark Kline, MD, of Children’s Hospital New Orleans, about the toolkit created by the Urgency of Normal group to promote resuming pre-COVID schooling and activities.
“My life and the lives of my family have been directly threatened throughout this pandemic from followers of this disinformation.” — Katelyn Jetelina, PhD, MPH, of UT Health Science Center at Houston, discussing the personal impact of disinformation on Substack.
“Brain health is likely to be a lifelong process, and the lack of curative solutions for dementia highlights the importance of prevention, starting early in midlife.” — Archana Singh-Manoux, PhD, of Université de Paris, on the link between multimorbidity and dementia.
“The death of a young person isn’t a single event. It is a tragedy that unfolds over a lifetime.” — O. Trent Hall, DO, of Ohio State University Wexner Medical Center in Columbus, on unintentional drug overdoses in young people.
“At age 50, about 18% of persons with normal cognition had abnormal amyloid, increasing to 54% at age 90.” — Willemijn Jansen, PhD, of Maastricht University in the Netherlands, discussing how common preclinical Alzheimer’s disease is.
“What we found is really, I think, quite unexpected.” — Andrew Marks, MD, of Columbia University in New York City, about brain changes found in a pathology study of people with COVID-19.